Femasys is trading at $2.69 (+6.32%), amid a generally risk-on market backdrop.

  • No new company-specific announcement dated September 21–22, 2026, was identified.
  • The latest notable update was September 15, when Minnesota Women’s Care adopted FemVue and FemaSeed across four locations.
  • Major-index gains were mixed, with Nasdaq up 0.48%; no definitive catalyst directly explains the September 22 move.